PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Computer Science, University of Colorado Boulder, Boulder, United States.\', \'BioFrontiers Institute, University of Colorado Boulder, Boulder, United States.\', \'Department of Statistics, Colorado State University, Fort Collins, United States.\', \'Department of Applied Mathematics, University of Colorado Boulder, Boulder, United States.\', \'IQ Biology Program, University of Colorado Boulder, Boulder, United States.\', \'Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, United States.\', \'Department of Ecology and Evolutionary Biology and the Woodrow Wilson School, Princeton University, Princeton, United States.\', \'Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, United States.\', \'Center for Communicable Disease Dynamics, Harvard T.H. Chan School of Public Health, Boston, United States.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.7554/eLife.64206e64206
?:hasPublicationType
?:journal
  • eLife
is ?:pmid of
?:pmid
?:pmid
  • 33666169
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 7.121
?:rankingScore_hIndex
  • 74
?:title
  • Estimating SARS-CoV-2 seroprevalence and epidemiological parameters with uncertainty from serological surveys.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all